Clinical trial
Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies
NCT02189174
Study timeline
Study start (actual)2014-08-07Date precision: day
Registry last updated2021-12-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Solid Tumorunresolved
Interventions
CLR457DRUG
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02189174 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.